Marco Pieraccioli
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
Papers in
-
- RNA Research and Splicing 9
- RNA modifications and cancer 7
- RNA and protein synthesis mechanisms 4
- Cancer-related gene regulation 3
- Genomics and Chromatin Dynamics 2
-
- Cancer-related molecular mechanisms research 3
- Co-authors
- Giuseppe Raschellà (8 shared papers)Gerry Melino (6 shared papers)Claudio Sette (11 shared papers)Sara Nicolai (5 shared papers)Pamela Bielli (6 shared papers)Cinzia Caggiano (6 shared papers)Michal Malewicz (3 shared papers)Angela Rachele Soliera (1 shared paper)
- Journals
- Nucleic Acids Research (3 papers)Journal of Experimental & Clinical Cancer Research (3 papers)Cell Death and Disease (2 papers)Oncogene (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- ItalyUnited KingdomJapan
In The Last Decade
Marco Pieraccioli
20 papers receiving 535 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 172
- Molecular Biology 407
- Oncology 94
- Neurology 51
- Complementary and alternative medicine 17
Countries citing papers authored by Marco Pieraccioli
This map shows the geographic impact of Marco Pieraccioli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Pieraccioli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Pieraccioli more than expected).
Fields of papers citing papers by Marco Pieraccioli
This network shows the impact of papers produced by Marco Pieraccioli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Pieraccioli. The network helps show where Marco Pieraccioli may publish in the future.
Co-authors
The 25 scholars most cited alongside Marco Pieraccioli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 119 | |
| 2 | 2015 | 47 | |
| 3 | 2018 | 41 | |
| 4 | 2013 | 40 | |
| 5 | 2018 | 38 | |
| 6 | 2015 | 38 | |
| 7 | 2019 | 30 | |
| 8 | 2023 | 25 | |
| 9 | 2019 | 24 | |
| 10 | 2017 | 24 | |
| 11 | 2019 | 23 | |
| 12 | 2020 | 16 | |
| 13 | 2022 | 15 | |
| 14 | 2023 | 15 | |
| 15 | 2022 | 14 | |
| 16 | 2019 | 11 | |
| 17 | 2023 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2024 | 2 |
About Marco Pieraccioli
Marco Pieraccioli is a scholar working on Molecular Biology, Cancer Research, Neurology, Oncology and Pathology and Forensic Medicine, having authored 20 papers that have together received 539 indexed citations. Recurring topics across this work include RNA Research and Splicing (9 papers), RNA modifications and cancer (7 papers), RNA and protein synthesis mechanisms (4 papers), Cancer-related molecular mechanisms research (3 papers), Cancer-related gene regulation (3 papers), Neuroblastoma Research and Treatments (3 papers), Genomics and Chromatin Dynamics (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Cancer Research (172 citations), Molecular Biology (407 citations), Oncology (94 citations), Neurology (51 citations) and Complementary and alternative medicine (17 citations). Marco Pieraccioli has collaborated with scholars based in Italy, United Kingdom and Japan. Frequent co-authors include Giuseppe Raschellà, Gerry Melino, Claudio Sette, Sara Nicolai, Pamela Bielli, Cinzia Caggiano, Michal Malewicz, Angela Rachele Soliera, Massimo Dominici and Mario P. Colombo. Their work appears in journals such as Nucleic Acids Research, Journal of Experimental & Clinical Cancer Research, Cell Death and Disease, Oncogene and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.